The use of direct acting oral anticoagulants in patients with COVID-19 infection

The use of direct-acting oral anticoagulants (DOACs) has increased rapidly in the last decade; becoming the mainstay for both the prophylaxis and the treatment of venous thromboembolism in various situations including non-valvular atrial fibrillation, joint replacement surgeries and acute DVT/PE, et...

Descripción completa

Detalles Bibliográficos
Autores principales: Aly, Ragia, Gupta, Sachin, Singh, Balraj, Kaur, Parminder, Kim, Kunhwa, Gupta, Sorab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043519/
https://www.ncbi.nlm.nih.gov/pubmed/33889317
http://dx.doi.org/10.1080/20009666.2020.1867295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043519/
https://www.ncbi.nlm.nih.gov/pubmed/33889317
http://dx.doi.org/10.1080/20009666.2020.1867295

Ejemplares similares